Research Article
Efficacy of Abiraterone and Enzalutamide in Pre- and Postdocetaxel Castration-Resistant Prostate Cancer: A Trial-Level Meta-Analysis
Table 3
Enzalutamide advantage over abiraterone (without and with adjustment for baseline Gleason score) in months ( value).
| ||||||||||||||||||||||||||||||
More detailed results are available in Supplemental S4 and S5. |